Hippocratic AI Adds Seven Senior Executives Across Operations, Legal, Government, Pharma, Partnerships, Marketing, and Finance As Company Expands into Next Generation of Healthcare AI

Hippocratic AI announced seven senior executive appointments across operations, legal, government solutions, pharma, global partnerships, marketing and finance.

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Tags

partnership AI

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

10/19/2026 - 10:19 AM EDT

MENLO PARK, Calif.--(BUSINESS WIRE)-- Hippocratic AI today announced seven senior executive appointments spanning operations, legal, government solutions, pharma, global partnerships, marketing, and finance.

The hires follow the company's August 13 launch of Agentic Orchestrators — teams of conversational voice AI agents coordinated by a supervising orchestration brain and focused on delivering outcomes, not tasks. Hippocratic AI introduced more than 30 orchestrators at launch across the payer, provider, pharma, and med tech segments.

Joining the company are Dan Litwer as Chief Operating Officer; Sasha Pesic as Chief Legal Officer; Greg Cioffi as Chief Growth Officer, Government Solutions; Stacey Wasserman as Chief Growth Officer, Pharma; Chad Compton as Senior Vice President, Global Partnerships; Evelyn Molloy as Senior Vice President, Marketing; and Arjet Skenduli as Vice President, Controller.

Dan Litwer

Dan Litwer joins as Chief Operating Officer, where he will lead the scale and growth of the Hippocratic AI platform. He has been a trusted executive partner to healthcare organizations for more than a decade, with a focus on building strategic relationships that put patients first, prioritize safety, and align with quality outcomes. Dan previously served as Executive Vice President at Press Ganey, healthcare's leading human experience platform.

Sasha Pesic

Sasha Pesic joins as Chief Legal Officer, bringing 30 years of experience across public and venture-backed technology companies, including more than two decades in combined General Counsel and Chief Operating Officer roles. That background gives him a practical combination of legal, operational, and strategic expertise in scaling global companies. He most recently served as Senior Vice President and General Counsel at C3 AI (NYSE: AI), where he led all legal, regulatory, governance, and compliance functions and won a unanimous $23.3 million jury verdict in a trade secret trial. Sasha holds a J.D. from UCLA School of Law and a B.A. from the University of California, Davis.

Greg Cioffi

Greg Cioffi joins as Chief Growth Officer, Government Solutions, bringing more than 20 years of experience growing federal health and civilian businesses. He most recently served as Vice President of Strategic Growth at Brillient Corporation, and before that spent over five years at NTT DATA Services as Sales Leader/Senior Director of Federal Health & Civilian, leading business development and capture across the company’s largest government clients. Greg has deep expertise in the federal procurement lifecycle and is a graduate of Virginia Tech.

Stacey Wasserman

Stacey Wasserman joins as Chief Growth Officer, Pharma, where she will lead commercial growth and partner with life sciences organizations to deploy AI-powered clinical engagement across patient services, field operations, and medical affairs. She brings more than 25 years of commercial leadership in life sciences, most recently in senior commercial roles at medication engagement platform Medisafe and previously as Chief Revenue Officer at BrightInsight. Stacey holds a B.S. from the University of Pennsylvania and an M.B.A. from Rutgers University.

Chad Compton

Chad Compton joins as Senior Vice President, Global Partnerships, bringing more than two decades of experience building partner ecosystems in healthcare and enterprise technology. He most recently served as Chief Revenue Officer at healthcare AI company Corti, and previously held leadership roles at Microsoft and Nuance Communications, where he oversaw one of the industry's most successful healthcare partnership sales organizations. Chad holds a B.S. from the University of California, San Diego and an M.B.A. from the University of Notre Dame.

Evelyn Molloy

Evelyn Molloy joins as Senior Vice President, Marketing, bringing more than 25 years of experience driving growth across healthcare and technology. She most recently served as Chief Marketing Officer at Residex, and previously led marketing and go-to-market strategy at PointClickCare, Cerner (now Oracle Health), UnitedHealthcare, Optum, and Mayo Clinic. Evelyn holds a master's in marketing from University College Dublin's Smurfit Graduate School of Business and a B.A. from the University of St. Thomas.

Arjet Skenduli

Arjet Skenduli joins as Vice President, Controller, bringing more than two decades of accounting and finance leadership across public and high-growth technology companies. He most recently served as Vice President, Finance and Corporate Controller at WEKA, and previously held chief accounting officer roles at Sysdig and Qualys, following earlier finance leadership at Talend and healthcare technology company Omnicell and roughly a decade in public accounting at PwC and KPMG. Arjet is a licensed CPA in California and holds a B.B.A. and a Master of Accountancy from Abilene Christian University.

About Hippocratic AI

Hippocratic AI builds and deploys safe conversational voice AI agents that address healthcare's biggest problems with a mission to transform patient outcomes through healthcare abundance. Built on Polaris, the company's patented, safety tested constellation model, Hippocratic AI's agents have completed more than 300 million patient voice interactions across more than 300 live clinical use cases, with zero safety issues in production. Hippocratic AI has received a total of $444 million in funding and is backed by leading investors, including Andreessen Horowitz, General Catalyst, Kleiner Perkins, Avenir, NVIDIA's NVentures, Premji Invest, SV Angel, Google's CapitalG, and numerous health systems. Hippocratic AI stands behind its safety promise — its contracts allow the company to take responsibility for its agents. Founded on the principle "do no harm," the company's agents do not diagnose or prescribe. Learn more at hippocraticai.com.